Santen Pharmaceutical Co., Ltd.
OTC: SNPHF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Takeshi Ito
- Employees
- 3,744
- Headquarters
- Osaka, Japan
- IPO year
- 2010
- Market cap
- $3.5B
- Website
- https://www.santen.com
Loading SNPHF…
Loading profile data…Frequently asked questions about SNPHF
What does Santen Pharmaceutical Co., Ltd. (SNPHF) do?
Santen Pharmaceutical Co., Ltd. is a global enterprise specializing in the research, development, manufacturing, and commercialization of pharmaceuticals and medical devices. Headquartered in Osaka, Japan, its core focus lies in ophthalmology. The company boasts a robust pipeline of treatments for various eye conditions. For glaucoma and ocular...
Where does SNPHF trade?
Santen Pharmaceutical Co., Ltd. (SNPHF) trades on the Other OTC.
What sector is SNPHF in?
Santen Pharmaceutical Co., Ltd. (SNPHF) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Santen Pharmaceutical Co., Ltd.?
Takeshi Ito is the chief executive officer of Santen Pharmaceutical Co., Ltd. (SNPHF).
Where is Santen Pharmaceutical Co., Ltd. headquartered?
Santen Pharmaceutical Co., Ltd. is headquartered in Japan.
Does SNPHF pay a dividend?
Yes — Santen Pharmaceutical Co., Ltd. (SNPHF) paid a trailing twelve-month dividend of USD 0.25 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did SNPHF go public?
Santen Pharmaceutical Co., Ltd. (SNPHF) completed its initial public offering in 2010.